160 related articles for article (PubMed ID: 31832201)
1. Role of equilibrative nucleoside transporter 1 (ENT1) in the disposition of cytarabine in mice.
Anderson JT; Hu S; Fu Q; Baker SD; Sparreboom A
Pharmacol Res Perspect; 2019 Dec; 7(6):e00534. PubMed ID: 31832201
[TBL] [Abstract][Full Text] [Related]
2. RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia.
Abraham A; Varatharajan S; Karathedath S; Philip C; Lakshmi KM; Jayavelu AK; Mohanan E; Janet NB; Srivastava VM; Shaji RV; Zhang W; Abraham A; Viswabandya A; George B; Chandy M; Srivastava A; Mathews V; Balasubramanian P
Pharmacogenomics; 2015 Jul; 16(8):877-90. PubMed ID: 26083014
[TBL] [Abstract][Full Text] [Related]
3. Variability in transport and biotransformation of cytarabine is associated with its toxicity in peripheral blood mononuclear cells.
Parmar S; Seeringer A; Denich D; Gärtner F; Pitterle K; Syrovets T; Ohmle B; Stingl JC
Pharmacogenomics; 2011 Apr; 12(4):503-14. PubMed ID: 21521023
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel point mutation in ENT1 that confers resistance to Ara-C in human T cell leukemia CCRF-CEM cells.
Zimmerman EI; Huang M; Leisewitz AV; Wang Y; Yang J; Graves LM
FEBS Lett; 2009 Jan; 583(2):425-9. PubMed ID: 19116148
[TBL] [Abstract][Full Text] [Related]
5. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling.
Miller SR; Zhang X; Hau RK; Jilek JL; Jennings EQ; Galligan JJ; Foil DH; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Mol Pharmacol; 2021 Feb; 99(2):147-162. PubMed ID: 33262250
[TBL] [Abstract][Full Text] [Related]
6. OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues.
Drenberg CD; Gibson AA; Pounds SB; Shi L; Rhinehart DP; Li L; Hu S; Du G; Nies AT; Schwab M; Pabla N; Blum W; Gruber TA; Baker SD; Sparreboom A
Cancer Res; 2017 Apr; 77(8):2102-2111. PubMed ID: 28209616
[TBL] [Abstract][Full Text] [Related]
7. DNA Methylation-Based Epigenetic Repression of SLC22A4 Promotes Resistance to Cytarabine in Acute Myeloid Leukemia.
Buelow DR; Anderson JT; Pounds SB; Shi L; Lamba JK; Hu S; Gibson AA; Goodwin EA; Sparreboom A; Baker SD
Clin Transl Sci; 2021 Jan; 14(1):137-142. PubMed ID: 32905646
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution and uptake of 3'-deoxy-3'-fluorothymidine in ENT1-knockout mice and in an ENT1-knockdown tumor model.
Paproski RJ; Wuest M; Jans HS; Graham K; Gati WP; McQuarrie S; McEwan A; Mercer J; Young JD; Cass CE
J Nucl Med; 2010 Sep; 51(9):1447-55. PubMed ID: 20720035
[TBL] [Abstract][Full Text] [Related]
9. Testicular disposition of clofarabine in rats is dependent on equilibrative nucleoside transporters.
Miller SR; Jilek JL; McGrath ME; Hau RK; Jennings EQ; Galligan JJ; Wright SH; Cherrington NJ
Pharmacol Res Perspect; 2021 Aug; 9(4):e00831. PubMed ID: 34288585
[TBL] [Abstract][Full Text] [Related]
10. Expression Levels of Human Equilibrative Nucleoside Transporter 1 and Deoxycytidine Kinase Enzyme as Prognostic Factors in Patients with Acute Myeloid Leukemia Treated with Cytarabine.
Candelaria M; Corrales-Alfaro C; Gutiérrez-Hernández O; Díaz-Chavez J; Labardini-Méndez J; Vidal-Millán S; Herrera LA
Chemotherapy; 2016; 61(6):313-8. PubMed ID: 27119162
[TBL] [Abstract][Full Text] [Related]
11. FLT3-ITD induces ara-C resistance in myeloid leukemic cells through the repression of the ENT1 expression.
Jin G; Matsushita H; Asai S; Tsukamoto H; Ono R; Nosaka T; Yahata T; Takahashi S; Miyachi H
Biochem Biophys Res Commun; 2009 Dec; 390(3):1001-6. PubMed ID: 19853583
[TBL] [Abstract][Full Text] [Related]
12. Gene-expression profiling reveals down-regulation of equilibrative nucleoside transporter 1 (ENT1) in Ara-C-resistant CCRF-CEM-derived cells.
Takagaki K; Katsuma S; Kaminishi Y; Horio T; Nakagawa S; Tanaka T; Ohgi T; Yano J
J Biochem; 2004 Nov; 136(5):733-40. PubMed ID: 15632314
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics of cytarabine in childhood leukemia.
Lamba JK
Pharmacogenomics; 2011 Dec; 12(12):1629-32. PubMed ID: 22118048
[No Abstract] [Full Text] [Related]
14. Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis.
Macanas-Pirard P; Leisewitz A; Broekhuizen R; Cautivo K; Barriga FM; Leisewitz F; Gidi V; Riquelme E; Montecinos VP; Swett P; Besa P; Ramirez P; Ocqueteau M; Kalergis AM; Holt M; Rettig M; DiPersio JF; Nervi B
PLoS One; 2012; 7(5):e37203. PubMed ID: 22629369
[TBL] [Abstract][Full Text] [Related]
15. Genetic factors influencing cytarabine therapy.
Lamba JK
Pharmacogenomics; 2009 Oct; 10(10):1657-74. PubMed ID: 19842938
[TBL] [Abstract][Full Text] [Related]
16. Cysteine residues in the transmembrane (TM) 9 to TM11 region of the human equilibrative nucleoside transporter subtype 1 play an important role in inhibitor binding and translocation function.
Park JS; Hammond JR
Mol Pharmacol; 2012 Nov; 82(5):784-94. PubMed ID: 22837314
[TBL] [Abstract][Full Text] [Related]
17. Multiple Computational Approaches for Predicting Drug Interactions with Human Equilibrative Nucleoside Transporter 1.
Miller SR; Lane TR; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Drug Metab Dispos; 2021 Jul; 49(7):479-489. PubMed ID: 33980604
[TBL] [Abstract][Full Text] [Related]
18. Hot shot induction and reperfusion with a specific blocker of the es-ENT1 nucleoside transporter before and after hypothermic cardioplegia abolishes myocardial stunning in acutely ischemic hearts despite metabolic derangement: hot shot drug delivery before hypothermic cardioplegia.
Abd-Elfattah AS; Tuchy GE; Jessen ME; Salter DR; Goldstein JP; Brunsting LA; Wechsler AS
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):961-970.e3. PubMed ID: 23422047
[TBL] [Abstract][Full Text] [Related]
19. The role of human equilibrative nucleoside transporter 1 on the cellular transport of the DNA methyltransferase inhibitors 5-azacytidine and CP-4200 in human leukemia cells.
Hummel-Eisenbeiss J; Hascher A; Hals PA; Sandvold ML; Müller-Tidow C; Lyko F; Rius M
Mol Pharmacol; 2013 Sep; 84(3):438-50. PubMed ID: 23814180
[TBL] [Abstract][Full Text] [Related]
20. Constrained NBMPR analogue synthesis, pharmacophore mapping and 3D-QSAR modeling of equilibrative nucleoside transporter 1 (ENT1) inhibitory activity.
Zhu Z; Buolamwini JK
Bioorg Med Chem; 2008 Apr; 16(7):3848-65. PubMed ID: 18289860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
